Vaxart IncNASDAQ:VXRT
- LAST PRICE3.7500
- TODAY'S CHANGE (%)0.2500 (7.1429%)
- Bid / Lots3.7300/ 1
- Ask / Lots3.7500/ 5
- Open / Previous Close3.4900 / 3.5000
- Day Range
- 52 Week Range
- Volume2,047,991
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VXRT |
|---|---|---|
| 09:32 ET | 56279 | 3.5 |
| 09:34 ET | 18929 | 3.51 |
| 09:36 ET | 15912 | 3.505 |
| 09:38 ET | 13316 | 3.52 |
| 09:39 ET | 4686 | 3.5 |
| 09:41 ET | 5118 | 3.51 |
| 09:43 ET | 4402 | 3.56 |
| 09:45 ET | 3270 | 3.56 |
| 09:48 ET | 2668 | 3.575 |
| 09:50 ET | 1730 | 3.585 |
| 09:52 ET | 13900 | 3.6299 |
| 09:54 ET | 22511 | 3.65 |
| 09:56 ET | 10852 | 3.625 |
| 09:57 ET | 27268 | 3.63 |
| 09:59 ET | 6320 | 3.63 |
| 10:01 ET | 8715 | 3.64 |
| 10:03 ET | 15085 | 3.615 |
| 10:06 ET | 14490 | 3.625 |
| 10:08 ET | 2503 | 3.64 |
| 10:10 ET | 12730 | 3.645 |
| 10:12 ET | 32347 | 3.63 |
| 10:14 ET | 25414 | 3.6409 |
| 10:15 ET | 28914 | 3.64 |
| 10:17 ET | 10800 | 3.64 |
| 10:19 ET | 8468 | 3.68 |
| 10:21 ET | 7257 | 3.69 |
| 10:24 ET | 6435 | 3.7058 |
| 10:26 ET | 4800 | 3.68 |
| 10:28 ET | 19369 | 3.6407 |
| 10:30 ET | 3787 | 3.63 |
| 10:32 ET | 14000 | 3.625 |
| 10:33 ET | 4300 | 3.63 |
| 10:35 ET | 2300 | 3.62 |
| 10:37 ET | 1755 | 3.6 |
| 10:39 ET | 7517 | 3.5991 |
| 10:42 ET | 4900 | 3.58 |
| 10:44 ET | 3796 | 3.59 |
| 10:46 ET | 2713 | 3.61 |
| 10:48 ET | 1300 | 3.62 |
| 10:50 ET | 7637 | 3.62 |
| 10:51 ET | 1392 | 3.6 |
| 10:53 ET | 6401 | 3.61 |
| 10:55 ET | 1400 | 3.62 |
| 10:57 ET | 6800 | 3.65 |
| 11:00 ET | 700 | 3.655 |
| 11:02 ET | 7282 | 3.6406 |
| 11:04 ET | 16090 | 3.6421 |
| 11:06 ET | 825 | 3.655 |
| 11:08 ET | 3349 | 3.66 |
| 11:09 ET | 8419 | 3.69 |
| 11:11 ET | 12116 | 3.69 |
| 11:13 ET | 1500 | 3.7 |
| 11:15 ET | 3007 | 3.72 |
| 11:18 ET | 17550 | 3.74 |
| 11:20 ET | 3875 | 3.72 |
| 11:22 ET | 2737 | 3.715 |
| 11:24 ET | 3304 | 3.715 |
| 11:26 ET | 3700 | 3.7107 |
| 11:27 ET | 4377 | 3.72 |
| 11:29 ET | 3294 | 3.71 |
| 11:31 ET | 4873 | 3.7199 |
| 11:33 ET | 3207 | 3.7112 |
| 11:36 ET | 1800 | 3.73 |
| 11:38 ET | 25891 | 3.7299 |
| 11:40 ET | 6782 | 3.725 |
| 11:42 ET | 4400 | 3.735 |
| 11:44 ET | 3889 | 3.73 |
| 11:45 ET | 5700 | 3.71 |
| 11:47 ET | 2300 | 3.715 |
| 11:49 ET | 10685 | 3.6807 |
| 11:51 ET | 5611 | 3.66 |
| 11:54 ET | 10881 | 3.655 |
| 11:56 ET | 2547 | 3.6799 |
| 11:58 ET | 1254 | 3.678 |
| 12:00 ET | 6505 | 3.675 |
| 12:02 ET | 1100 | 3.665 |
| 12:03 ET | 11564 | 3.655 |
| 12:05 ET | 2500 | 3.66 |
| 12:07 ET | 12897 | 3.66 |
| 12:09 ET | 1650 | 3.6597 |
| 12:12 ET | 4200 | 3.6599 |
| 12:14 ET | 1300 | 3.659 |
| 12:16 ET | 3300 | 3.66 |
| 12:18 ET | 7290 | 3.67 |
| 12:20 ET | 6521 | 3.685 |
| 12:21 ET | 13402 | 3.695 |
| 12:23 ET | 4501 | 3.69 |
| 12:25 ET | 4800 | 3.685 |
| 12:27 ET | 1100 | 3.7 |
| 12:30 ET | 1050 | 3.698 |
| 12:32 ET | 300 | 3.695 |
| 12:34 ET | 2650 | 3.685 |
| 12:36 ET | 3300 | 3.68 |
| 12:38 ET | 5160 | 3.67 |
| 12:39 ET | 3901 | 3.6699 |
| 12:41 ET | 852 | 3.66 |
| 12:43 ET | 5162 | 3.665 |
| 12:45 ET | 1527 | 3.66 |
| 12:48 ET | 4900 | 3.655 |
| 12:50 ET | 1475 | 3.66 |
| 12:52 ET | 300 | 3.67 |
| 12:54 ET | 1050 | 3.665 |
| 12:56 ET | 8656 | 3.66 |
| 12:57 ET | 9423 | 3.64 |
| 12:59 ET | 3397 | 3.62 |
| 01:01 ET | 5250 | 3.62 |
| 01:03 ET | 1113 | 3.605 |
| 01:06 ET | 400 | 3.6 |
| 01:08 ET | 13414 | 3.595 |
| 01:10 ET | 1300 | 3.6 |
| 01:12 ET | 2777 | 3.615 |
| 01:14 ET | 400 | 3.615 |
| 01:15 ET | 4513 | 3.635 |
| 01:17 ET | 2974 | 3.615 |
| 01:19 ET | 250 | 3.62 |
| 01:21 ET | 680 | 3.63 |
| 01:24 ET | 300 | 3.625 |
| 01:26 ET | 4900 | 3.63 |
| 01:28 ET | 833 | 3.625 |
| 01:30 ET | 2220 | 3.635 |
| 01:32 ET | 3000 | 3.64 |
| 01:33 ET | 2101 | 3.645 |
| 01:35 ET | 1800 | 3.6424 |
| 01:37 ET | 800 | 3.645 |
| 01:39 ET | 5002 | 3.66 |
| 01:42 ET | 3000 | 3.65 |
| 01:44 ET | 3400 | 3.65 |
| 01:46 ET | 800 | 3.655 |
| 01:48 ET | 3555 | 3.655 |
| 01:50 ET | 300 | 3.66 |
| 01:51 ET | 5669 | 3.665 |
| 01:53 ET | 600 | 3.66 |
| 01:55 ET | 3662 | 3.6601 |
| 01:57 ET | 1300 | 3.66 |
| 02:00 ET | 500 | 3.66 |
| 02:02 ET | 300 | 3.6536 |
| 02:04 ET | 4604 | 3.65 |
| 02:06 ET | 2900 | 3.65 |
| 02:08 ET | 4000 | 3.649 |
| 02:09 ET | 1725 | 3.64 |
| 02:11 ET | 1700 | 3.64 |
| 02:13 ET | 4700 | 3.64 |
| 02:15 ET | 35819 | 3.65 |
| 02:18 ET | 6703 | 3.65 |
| 02:20 ET | 345 | 3.655 |
| 02:22 ET | 2950 | 3.655 |
| 02:24 ET | 4923 | 3.669 |
| 02:26 ET | 20536 | 3.676 |
| 02:27 ET | 2149 | 3.68 |
| 02:29 ET | 2850 | 3.67 |
| 02:31 ET | 500 | 3.675 |
| 02:33 ET | 4672 | 3.685 |
| 02:36 ET | 9700 | 3.68 |
| 02:38 ET | 4248 | 3.675 |
| 02:40 ET | 2545 | 3.685 |
| 02:42 ET | 2800 | 3.6768 |
| 02:44 ET | 5200 | 3.685 |
| 02:45 ET | 1400 | 3.69 |
| 02:47 ET | 4499 | 3.7 |
| 02:49 ET | 13559 | 3.705 |
| 02:51 ET | 15427 | 3.695 |
| 02:54 ET | 1500 | 3.7 |
| 02:56 ET | 15660 | 3.6845 |
| 02:58 ET | 5500 | 3.695 |
| 03:00 ET | 3660 | 3.7 |
| 03:02 ET | 4509 | 3.69 |
| 03:03 ET | 4692 | 3.675 |
| 03:05 ET | 5203 | 3.68 |
| 03:07 ET | 518 | 3.6824 |
| 03:09 ET | 8188 | 3.695 |
| 03:12 ET | 13305 | 3.7 |
| 03:14 ET | 320 | 3.7 |
| 03:16 ET | 1600 | 3.695 |
| 03:18 ET | 5000 | 3.698 |
| 03:20 ET | 1195 | 3.69 |
| 03:21 ET | 4600 | 3.68 |
| 03:23 ET | 7736 | 3.69 |
| 03:25 ET | 11069 | 3.69 |
| 03:27 ET | 1973 | 3.69 |
| 03:30 ET | 4918 | 3.69 |
| 03:32 ET | 4240 | 3.7 |
| 03:34 ET | 5862 | 3.69 |
| 03:36 ET | 3163 | 3.69 |
| 03:38 ET | 4898 | 3.7 |
| 03:39 ET | 9064 | 3.7 |
| 03:41 ET | 21270 | 3.7 |
| 03:43 ET | 6075 | 3.71 |
| 03:45 ET | 8090 | 3.7 |
| 03:48 ET | 27897 | 3.715 |
| 03:50 ET | 13186 | 3.7101 |
| 03:52 ET | 30959 | 3.725 |
| 03:54 ET | 15161 | 3.71 |
| 03:56 ET | 30626 | 3.735 |
| 03:57 ET | 20412 | 3.74 |
| 03:59 ET | 135142 | 3.75 |
Today
Vaxart Urges Shareholders to Vote for Proxy Proposals, Including Increasing Authorized Shares, from 5 hours ago by MT Newswires
5 hours ago by MT NewswiresBRIEF-Vaxart Provides An Update On Proxy Voting And Urges All Stockholders Of Record As Of April 11, 2022 To Vote By July 5, 2022, At 1159 P.M. Et, from 7 hours ago by Thomson Reuters
7 hours ago by Thomson ReutersVaxart Provides an Update on Proxy Voting and Urges All Stockholders of Record as of April 11, 2022 to Vote by July 5, 2022, at 11:59 p.m. ET, from 7 hours ago by GlobeNewswire
7 hours ago by GlobeNewswire
Yesterday
BRIEF-Vaxart Announces Agreement With Hvivo To Develop World’S First Human Omicron Challenge Model, from 8:02AM ET on Thursday Jun 30, 2022 by Thomson Reuters
8:02AM ET on Thursday Jun 30, 2022 by Thomson ReutersVaxart Announces Agreement with hVIVO to Develop World's First Human Omicron Challenge Model, from 8:00AM ET on Thursday Jun 30, 2022 by GlobeNewswire
8:00AM ET on Thursday Jun 30, 2022 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vaxart Inc | 442.6M | -5.9x | --- |
Mersana Therapeutics Inc | 448.1M | -1.9x | --- |
Prenetics Global Ltd | 448.4M | 29.4x | --- |
Regencell Bioscience Holdings Ltd | 448.7M | -336.8x | --- |
Monte Rosa Therapeutics Inc | 451.3M | -4.4x | --- |
Imago BioSciences Inc | 451.7M | -8.9x | --- |
Company Information
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. Its programs include tablet vaccines designed to protect against coronavirus, norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV). The Company’s product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection. The Company is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus.
Contact Information
- Headquarters
- 170 Harbor Way, Suite 300SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-550-3500
- Fax
- 650-871-8580
Executives
- Independent Chairman of the Board
- Todd Davis
- President, Chief Executive Officer, Director
- Andrei Floroiu
- Interim Chief Financial Officer
- Fuad Ahmad
- Senior Vice President, Chief Scientific Officer
- Sean Tucker
- Senior Vice President, General Counsel
- Edward Berg
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $442.6M |
|---|---|
Revenue (TTM) | $471.0K |
Shares Outstanding | 126.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.72 |
EPS | $-0.64 |
Book Value | $1.49 |
P/E Ratio | -5.9x |
Price/Sales (TTM) | 939.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -16,608.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
